Search for: "Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc." Results 21 - 40 of 44
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2018, 11:23 am by Tryn T. Stimart and Jean E. Dassie
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
31 Jan 2019, 8:32 am
TEVA Pharmaceuticals USA INC., et al.,  had the opportunity to interpret the Leahy-Smith America Invents Act (AIA) with respect to how this impacts on the issue of the novelty of an invention. [read post]
25 Jun 2018, 7:03 am by Dennis Crouch
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
18 Jun 2018, 9:15 am by Dennis Crouch
by Dennis Crouch In the pending case of Helsinn Healthcare S.A. v. [read post]
2 Dec 2018, 9:00 am by Andrew Hamm
Teva Pharmaceuticals USA Inc. [read post]
2 Feb 2018, 1:31 pm by Gregory Sephton
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
27 Nov 2018, 9:30 am by Ronald Mann
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
29 Jan 2019, 6:32 am by Andrew Hamm
” In The National Law Journal, Courtenay Brinckerhoff and Daniel Shelton look at Helsinn Healthcare S.A. v. [read post]
28 Jan 2019, 7:17 am by Andrew Hamm
Subscript Law has a graphic explainer for Helsinn Healthcare S.A. v. [read post]
21 Mar 2018, 1:34 pm by Pierre T. Nguyen
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
4 Mar 2024, 9:45 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
13 Dec 2018, 11:16 am by Adam Feldman
Teva Pharmaceuticals USA Inc., which asks: “Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]